Latest news articles

Added 29 days ago Drug news

IDMC recommends early halt of phase III SANET-p study of HMPL 012 in neuroendocrine tumors – pancreatic.- Hutchison China MediTech

Hutchison China MediTech Limited announced that the independent Data Monitoring Committee of the Phase III pivotal study of HMPL 012...

Added 8 months ago Drug news

Surufatinib in advanced neuroendocrine tumors – extra-pancreatic,met the primary endpoint of progression free survival

Hutchison China MediTech announced that the independent Data Monitoring Committee of the Phase III pivotal study of surufatinib in advanced...

Added 1 year ago Drug news

FDA grants accelerated approval for Keytruda to treat Merkel call carcinoma. Merck Inc.

Merck Inc., announced that the FDA has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients...

Search all news articles for Malignant neoplasm, unspecified site

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Load more

Journal articles

Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.

Background: Liver transplantation to treat neuroendocrine tumors, especially in the setting of diffuse liver involvement not amenable to operative resection remains controversial. We sought to perform a systematic review...

Added 2 years ago

Evaluation of Lanreotide Depot/Autogel efficacy and safety as a carcinoid syndrome treatment (ELECT): a randomized, double-blind, placebo-controlled trial.

Objective: To evaluate the efficacy and safety of lanreotide depot/autogel 120mg for the control of carcinoid syndrome (CS) symptoms in...

Added 3 years ago

Search all journal articles for Malignant neoplasm, unspecified site


Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
Registration required
Subscription fee
Search all CME for Malignant neoplasm, unspecified site